Research Article
Characterization of CD30/CD30L+ Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis
Table 1
CD30+ and CD30L+ T cells phenotype in the peripheral blood and synovial fluid of RA patients and controls.
| RA patients () | Sample |
CD3+ CD4+ | CD3+ CD8+ | CD4+ CD30+ | CD4+ CD30L+ | CD8+ CD30+ | CD8+ CD30L+ | Treg | Treg CD30+ |
| Mean ± S.D. | PB | 73.9 ± 12.5 | 23.8 ± 12.3 | 0.8 ± 0.7 | 2.9 ± 1.8 | 0.1 ± 0.2 | 2.1 ± 0.2 | 5.0 ± 3.8 | 12.5 ± 15.2 | Mean ± S.D. | SF | 58.0 ± 10.7 | 38.8 ± 11.2 | 8.6 ± 5.6 | 13.9 ± 10.4 | 0.3 ± 0.5 | 2.3 ± 3.2 | 13.8 ± 4.8 | 42.3 ± 14.7 |
| Controls () | Sample | CD3+ CD4+ | CD3+ CD8+ | CD4+ CD30+ | CD4+ CD30L+ | CD8+ CD30+ | CD8+ CD30L+ | Treg | Treg CD30+ |
| Mean ± S.D. | PB | 72.3 ± 9.5 | 22.3 ± 10.2 | 0.3 ± 0.5 | 3.2 ± 0.9 | 0.3 ± 0.5 | 1.7 ± 1.7 | 4.5 ± 1.8 | 4.1 ± 4.3 | Mean ± S.D. | SF | 62.0 ± 7.1 | 33.0 ± 4.2 | 0.5 ± 0.7 | 10.0 ± 1.4 | 0.5 ± 0.7 | 6.9 ± 5.8 | 4.0 ± 2.8 | 19.0 ± 11.3 |
|
|